Header Logo

Connection

Kathleen Moore to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Kathleen Moore has written about Antibodies, Monoclonal.
Kathleen Moore
Connection Strength
0.090
Antibodies, Monoclonal
  1. A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study. Gynecol Oncol. 2012 Dec; 127(3):456-61.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.